Celgene Corporation Contingent Value Rights
CELGZ
CELGZ was delisted on the 29th of November, 2019.
25 hedge funds and large institutions have $2.68M invested in Celgene Corporation Contingent Value Rights in 2015 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
9% more funds holding
Funds holding: 23 → 25 (+2)
30% less capital invested
Capital invested by funds: $3.84M → $2.68M (-$1.16M)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Birchview Capital
Burlington,
Vermont
|
+$47.8K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$23.3K |
| 3 |
FA
FCG Advisors
Chatham,
New Jersey
|
+$8.41K |
| 4 |
MC
Muhlenkamp & Co
Wexford,
Pennsylvania
|
+$6.22K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.17K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$225K |
| 2 |
Millennium Management
New York
|
-$163K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$46K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$3.3K |
| 5 |
California Public Employees Retirement System
Sacramento,
California
|
-$1.35K |
CELGZ Hedge Fund Activity: Q3 2015 in Review
25 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Celgene Corporation Contingent Value Rights (CELGZ) for Q3 2015, worth a combined $2.68M — down 30% from $3.84M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CELGZ positions and 2 closed out — a net gain of 2 holders — while 4 added to existing stakes and 6 trimmed.
The largest buyer was Birchview Capital, adding an estimated $47.8K. The largest seller was Opaleye Management, cutting an estimated $225K.
- 25 institutional investors held Celgene Corporation Contingent Value Rights (CELGZ) as of Q3 2015, up from 23 in Q2 2015.
- Funds reported $2.68M of Celgene Corporation Contingent Value Rights stock for Q3 2015, down 30% quarter-over-quarter.
- 4 funds opened new Celgene Corporation Contingent Value Rights positions in Q3 2015 and 2 closed out, a net change of +2 holders.
- The largest Celgene Corporation Contingent Value Rights buyer in Q3 2015 was Birchview Capital, an estimated $47.8K added.
- The largest Celgene Corporation Contingent Value Rights seller in Q3 2015 was Opaleye Management, an estimated $225K sold.
Based on aggregated 13F filings for Q3 2015.